SYNARTRO
Synartro is a Swedish research and development company that develops improved treatments using patented delivery technology combined with existing proven drugs. The preclinical lead program, SYN321, is based on a novel therapy combining diclofenac covalently bound to hyaluronan for the treatment of osteoarthritis (OA), a disease that today leaves up to 50% of patients without adequate pain relief. The company’s initial focus is in knee OA with the potential of further expansion.
SYNARTRO
Industry:
Biotechnology Therapeutics
Founded:
2011-01-01
Address:
Uppsala, Uppsala Lan, Sweden
Country:
Sweden
Website Url:
http://www.synartro.com
Total Employee:
1+
Status:
Active
Total Funding:
5.67 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx PHP
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.synartro.com
- Host name: webfront2.webcluster.loopia.se
- IP address: 93.188.2.52
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
Loading ... 